Matthew Maxwell Donley, Ex VP, Internal Operations at Aurinia Pharmaceuticals Inc. (AUPH), bought 10,000 shares at $4.66 ($47K) on 2022-11-21, disclosed to the SEC on 2022-11-23.
Open-market purchase of $47k AUPH by Ex VP, Internal Operations. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| AUPH | SELL | 2022-03-04 | $37K | — | Filing → |
| AUPH | BUY | 2021-05-12 | $100K | — | Filing → |